Neoadjuvant Therapy

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, IMMUNOTHERAPY, HYPERTHERMIA, INDUCED etc.) that is given before the main therapy.

Also Known As:

Chemoradiation Therapy, Neoadjuvant; Chemoradiation Treatment, Neoadjuvant; Chemoradiation, Neoadjuvant; Chemoradiotherapy, Neoadjuvant; Chemotherapy Treatment, Neoadjuvant; Chemotherapy, Neoadjuvant; Neoadjuvant Chemoradiation Therapies; Neoadjuvant Chemoradiation Treatments; Neoadjuvant Chemoradiations; Neoadjuvant Chemoradiotherapies; Neoadjuvant Chemotherapies; Neoadjuvant Chemotherapy Treatments; Neoadjuvant Radiation Therapies; Neoadjuvant Radiation Treatments; Neoadjuvant Radiations; Neoadjuvant Radiotherapies; Neoadjuvant Systemic Therapies; Neoadjuvant Systemic Treatments; Neoadjuvant Therapies; Neoadjuvant Treatments; Radiation Therapy, Neoadjuvant; Radiation Treatment, Neoadjuvant; Radiation, Neoadjuvant; Radiotherapy, Neoadjuvant; Systemic Therapy, Neoadjuvant; Systemic Treatment, Neoadjuvant; Therapy, Neoadjuvant; Therapy, Neoadjuvant Chemoradiation; Therapy, Neoadjuvant Radiation; Therapy, Neoadjuvant Systemic; Treatment, Neoadjuvant; Treatment, Neoadjuvant Chemoradiation; Treatment, Neoadjuvant Chemotherapy; Treatment, Neoadjuvant Radiation; Treatment, Neoadjuvant Systemic; Neoadjuvant Chemoradiation; Neoadjuvant Chemoradiation Therapy; Neoadjuvant Chemoradiation Treatment; Neoadjuvant Chemoradiotherapy; Neoadjuvant Chemotherapy; Neoadjuvant Chemotherapy Treatment; Neoadjuvant Radiation; Neoadjuvant Radiation Therapy; Neoadjuvant Radiation Treatment; Neoadjuvant Radiotherapy; Neoadjuvant Systemic Therapy; Neoadjuvant Systemic Treatment; Neoadjuvant Treatment

Therapeutics: 1190486
- Combined Modality Therapy: 4433
  - Neoadjuvant Therapy: 28715

Laure-Sophie Talagrand Selected Research

Laure-Sophie Talagrand Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure